Travere Therapeutics, Inc. (TVTX)
USD 14.51
(-3.2%)
USD 14.51
(-3.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -376.74 Million USD | -49.76% |
| 2022 | -251.56 Million USD | -80.32% |
| 2021 | -139.5 Million USD | -85.08% |
| 2020 | -75.37 Million USD | 24.48% |
| 2019 | -99.81 Million USD | -24.7% |
| 2018 | -80.04 Million USD | -48.8% |
| 2017 | -53.79 Million USD | 7.6% |
| 2016 | -58.21 Million USD | -14.71% |
| 2015 | -50.74 Million USD | 36.41% |
| 2014 | -79.8 Million USD | -232.92% |
| 2013 | -23.97 Million USD | 20.71% |
| 2012 | -30.23 Million USD | -235651.95% |
| 2011 | -12.82 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -18.26 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -139.23 Million USD | -68.08% |
| 2024 Q3 | -54.75 Million USD | 18.34% |
| 2024 Q2 | -67.05 Million USD | 51.84% |
| 2023 Q4 | -82.83 Million USD | 7.17% |
| 2023 Q2 | -87.58 Million USD | -9.08% |
| 2023 Q3 | -89.24 Million USD | -1.9% |
| 2023 FY | -376.74 Million USD | -49.76% |
| 2023 Q1 | -80.29 Million USD | -16.34% |
| 2022 Q3 | -64.95 Million USD | 0.76% |
| 2022 Q4 | -69.01 Million USD | -6.25% |
| 2022 FY | -251.56 Million USD | -80.32% |
| 2022 Q2 | -65.45 Million USD | -14.73% |
| 2022 Q1 | -57.05 Million USD | -20.89% |
| 2021 FY | -139.5 Million USD | -85.08% |
| 2021 Q4 | -47.19 Million USD | -48.81% |
| 2021 Q1 | -47.54 Million USD | 59.89% |
| 2021 Q2 | -35.31 Million USD | 25.73% |
| 2021 Q3 | -31.71 Million USD | 10.21% |
| 2020 Q4 | -118.55 Million USD | -509.98% |
| 2020 Q3 | -19.43 Million USD | 15.91% |
| 2020 Q1 | -15.06 Million USD | 46.51% |
| 2020 Q2 | -23.11 Million USD | -53.39% |
| 2020 FY | -75.37 Million USD | 24.48% |
| 2019 Q3 | -34.43 Million USD | 5.73% |
| 2019 FY | -99.81 Million USD | -24.7% |
| 2019 Q1 | -38.22 Million USD | -666.86% |
| 2019 Q2 | -36.52 Million USD | 4.44% |
| 2019 Q4 | -28.16 Million USD | 18.2% |
| 2018 Q1 | -17.91 Million USD | -18.02% |
| 2018 FY | -80.04 Million USD | -48.8% |
| 2018 Q4 | -4.98 Million USD | 85.99% |
| 2018 Q3 | -35.58 Million USD | -65.04% |
| 2018 Q2 | -21.56 Million USD | -20.37% |
| 2017 Q3 | -10.6 Million USD | 21.99% |
| 2017 Q1 | -14.4 Million USD | 20.93% |
| 2017 FY | -53.79 Million USD | 7.6% |
| 2017 Q4 | -15.17 Million USD | -43.07% |
| 2017 Q2 | -13.59 Million USD | 5.62% |
| 2016 Q1 | -8.24 Million USD | 45.8% |
| 2016 Q3 | -20.37 Million USD | -79.03% |
| 2016 FY | -58.21 Million USD | -14.71% |
| 2016 Q4 | -18.22 Million USD | 10.55% |
| 2016 Q2 | -11.37 Million USD | -38.08% |
| 2015 FY | -50.74 Million USD | 36.41% |
| 2015 Q4 | -15.2 Million USD | 25.82% |
| 2015 Q1 | -8.1 Million USD | 57.14% |
| 2015 Q3 | -20.49 Million USD | -200.35% |
| 2015 Q2 | -6.82 Million USD | 15.8% |
| 2014 Q4 | -18.9 Million USD | 19.34% |
| 2014 FY | -79.8 Million USD | -232.92% |
| 2014 Q1 | -16.95 Million USD | -47.83% |
| 2014 Q2 | -20.5 Million USD | -20.95% |
| 2014 Q3 | -23.44 Million USD | -14.34% |
| 2013 Q4 | -11.46 Million USD | -122.47% |
| 2013 FY | -23.97 Million USD | 20.71% |
| 2013 Q1 | -2.25 Million USD | -71095.32% |
| 2013 Q2 | -5.09 Million USD | -126.61% |
| 2013 Q3 | -5.15 Million USD | -1.07% |
| 2012 Q2 | -3009.00 USD | 19.93% |
| 2012 FY | -30.23 Million USD | -235651.95% |
| 2012 Q3 | -3000.00 USD | 0.3% |
| 2012 Q4 | -3161.00 USD | -5.37% |
| 2012 Q1 | -3758.00 USD | -24.52% |
| 2011 Q1 | -3580.00 USD | -15.82% |
| 2011 Q2 | -3024.00 USD | 15.53% |
| 2011 Q3 | -3525.00 USD | -16.57% |
| 2011 FY | -12.82 Thousand USD | 0.0% |
| 2011 Q4 | -3018.00 USD | 14.38% |
| 2010 Q2 | -6644.00 USD | -131.66% |
| 2010 Q4 | -3091.00 USD | 53.35% |
| 2010 Q3 | -6626.00 USD | 0.27% |
| 2010 Q1 | 20.98 Thousand USD | 415.82% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | -7645.00 USD | 0.0% |
| 2009 Q4 | -6644.00 USD | 0.75% |
| 2009 Q3 | -6694.00 USD | 12.44% |
| 2009 FY | - USD | 100.0% |
| 2008 Q2 | -3376.00 USD | 0.0% |
| 2008 Q3 | -3050.00 USD | 9.66% |
| 2008 FY | -18.26 Thousand USD | 0.0% |
| 2008 Q4 | -4251.00 USD | -39.38% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -58.825% |
| Alkermes plc | 414.12 Million USD | 190.974% |
| Agenus Inc. | -159.54 Million USD | -136.131% |
| Aptorum Group Limited | -10.52 Million USD | -3480.083% |
| Ardelyx, Inc. | -63.27 Million USD | -495.398% |
| Dyadic International, Inc. | -8.22 Million USD | -4477.837% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -31506.04% |
| Lantern Pharma Inc. | -17.87 Million USD | -2007.356% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1775.301% |
| Novavax, Inc. | -566.51 Million USD | 33.497% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -416.236% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -358.348% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1840.128% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3466.638% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -609.147% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 0.986% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1449.965% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -894.861% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -192.077% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -348.964% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2048.036% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -756.042% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1416.439% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -170.978% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -33.514% |
| AlloVir, Inc. | -181.33 Million USD | -107.766% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -83.776% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1187.661% |
| Bicycle Therapeutics plc | -189.94 Million USD | -98.343% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -119.315% |
| ChromaDex Corporation | -5.59 Million USD | -6628.773% |
| Chimerix, Inc. | -93.06 Million USD | -304.818% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -735.773% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -224.614% |
| CRISPR Therapeutics AG | -222.53 Million USD | -69.294% |
| Precision BioSciences, Inc. | -43.73 Million USD | -761.405% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -97.754% |
| Fortress Biotech, Inc. | -142.34 Million USD | -164.675% |
| Fortress Biotech, Inc. | -142.34 Million USD | -164.675% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -285.637% |
| ImmuCell Corporation | -5.74 Million USD | -6454.26% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -180.255% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2234.065% |
| Incyte Corporation | 620.52 Million USD | 160.714% |
| Innoviva, Inc. | 176.7 Million USD | 313.2% |
| IO Biotech, Inc. | -91.44 Million USD | -311.999% |
| Jaguar Health, Inc. | -34.29 Million USD | -998.667% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -121.691% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3254.781% |
| ContextLogic Inc. | -328 Million USD | -14.861% |
| MiMedx Group, Inc. | 37.11 Million USD | 1115.045% |
| MEI Pharma, Inc. | 14.54 Million USD | 2690.73% |
| NextCure, Inc. | -67.63 Million USD | -457.009% |
| Onconetix, Inc. | -36.03 Million USD | -945.506% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -803.16% |
| Opthea Limited | -191.84 Million USD | -96.382% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13590.696% |
| Vaxcyte, Inc. | -468.04 Million USD | 19.506% |
| PDS Biotechnology Corporation | -43.04 Million USD | -775.228% |
| Precigen, Inc. | -88.92 Million USD | -323.674% |
| Pharming Group N.V. | -4.87 Million USD | -7620.885% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -125.175% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1166.111% |
| PureTech Health plc | -146.19 Million USD | -157.693% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1738.583% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -59.91% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1449.965% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -37.495% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1185.596% |
| Acelyrin, Inc. | -422.06 Million USD | 10.738% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2921542.132% |
| Summit Therapeutics Inc. | -89.73 Million USD | -319.836% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -916.469% |
| Senti Biosciences, Inc. | -92.72 Million USD | -306.294% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -228.251% |
| Elevation Oncology, Inc. | -45.44 Million USD | -729.011% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -999.437% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -9457.063% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -11814.738% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1040.922% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4331.761% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -454.068% |
| Seer, Inc. | -103.46 Million USD | -264.134% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -472.916% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -423.743% |
| ESSA Pharma Inc. | -32.13 Million USD | -1072.412% |
| GlycoMimetics, Inc. | -39.27 Million USD | -859.239% |
| GT Biopharma, Inc. | -13.57 Million USD | -2675.074% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -71.856% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -714.476% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 533.977% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -563.761% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -631.457% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3691.079% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 25.296% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -5361.641% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -643.187% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -45.092% |
| Aptose Biosciences Inc. | -52.35 Million USD | -619.581% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2512.509% |
| Soligenix, Inc. | -7.69 Million USD | -4794.089% |
| Century Therapeutics, Inc. | -146.54 Million USD | -157.082% |
| Kura Oncology, Inc. | -165.8 Million USD | -127.223% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -303.116% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4428.717% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -15081.257% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5710.364% |
| Autolus Therapeutics plc | -195.02 Million USD | -93.174% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -345.024% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -411.45% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1682.56% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -65.941% |
| GRI Bio, Inc. | -11.38 Million USD | -3208.545% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8242.953% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -187.168% |
| IGM Biosciences, Inc. | -263.46 Million USD | -42.998% |
| INmune Bio, Inc. | -29.74 Million USD | -1166.75% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -240.59% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -889.47% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2257.691% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2288.866% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -516.622% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -250.388% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -36.498% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -85.406% |
| Verastem, Inc. | -92.08 Million USD | -309.131% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -699.287% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -104.591% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -218.25% |
| Histogen Inc. | -10.64 Million USD | -3439.829% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2335.011% |
| Surrozen, Inc. | -45.78 Million USD | -722.945% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2397.309% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7301.307% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -535.517% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -634.48% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1390.285% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -4835.828% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -119.954% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -677.626% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -381.739% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2375.196% |
| Apollomics, Inc. | -54.83 Million USD | -587.063% |
| Amarin Corporation plc | -67.58 Million USD | -457.413% |
| Mesoblast Limited | -58.79 Million USD | -540.786% |
| Turnstone Biologics Corp. | -59.03 Million USD | -538.203% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -127.599% |
| Synaptogenix, Inc. | -8.31 Million USD | -4431.521% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2482.915% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -310.884% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7762.813% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4166.04% |
| Exelixis, Inc. | 170.88 Million USD | 320.466% |
| Better Therapeutics, Inc. | -38.26 Million USD | -884.643% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -142.962% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 27.146% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3090.836% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4584.76% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1156.106% |
| Gritstone bio, Inc. | -154.63 Million USD | -143.636% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -447.108% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2100.215% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1917.047% |
| Insmed Incorporated | -709.62 Million USD | 46.909% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2301.205% |
| MediWound Ltd. | -15.29 Million USD | -2363.99% |
| OmniAb, Inc. | -69.41 Million USD | -442.71% |
| Alector, Inc. | -151.74 Million USD | -148.283% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -248.892% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -622.451% |
| Zai Lab Limited | -366.57 Million USD | -2.775% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -18.93% |
| Aura Biosciences, Inc. | -84.99 Million USD | -343.275% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -53.461% |
| Immunic, Inc. | -99.22 Million USD | -279.694% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -163.167% |
| Veracyte, Inc. | -85.79 Million USD | -339.121% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -33.685% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2551.26% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -5369.612% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1904.745% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 165.115% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1380.156% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1070.94% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1925.929% |
| Galecto, Inc. | -39.9 Million USD | -844.102% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -795.432% |
| Fortrea Holdings Inc. | 63.1 Million USD | 697.059% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -168.25% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1204.606% |
| XBiotech Inc. | -37.51 Million USD | -904.383% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -447.108% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -461.299% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -249.141% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1367.529% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -606.943% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 33.813% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -379.978% |
| Vaxxinity, Inc. | -58.28 Million USD | -546.382% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -263.27% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1592.993% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -335.966% |
| NexImmune, Inc. | -29.19 Million USD | -1190.552% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6603.472% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2483.734% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 109.309% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1379.807% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3115.945% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -196.504% |
| Ainos, Inc. | -13.2 Million USD | -2752.739% |
| Pluri Inc. | -22.15 Million USD | -1600.262% |
| Prothena Corporation plc | -191.03 Million USD | -97.211% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -172.928% |
| Celularity Inc. | -192.28 Million USD | -95.928% |
| Rallybio Corporation | -78.93 Million USD | -377.302% |
| Cue Biopharma, Inc. | -52.14 Million USD | -622.438% |
| MeiraGTx Holdings plc | -137.06 Million USD | -174.873% |
| Omeros Corporation | -164.53 Million USD | -128.982% |
| Humacyte, Inc. | -100.04 Million USD | -276.567% |
| Immunocore Holdings plc | -59.64 Million USD | -531.602% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1929.98% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1438.798% |
| Blueprint Medicines Corporation | -486.27 Million USD | 22.525% |
| CalciMedica, Inc. | -21.87 Million USD | -1622.258% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -404.613% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -186.53% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -119.939% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -15.247% |
| Pulmatrix, Inc. | -14.74 Million USD | -2455.929% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -953.977% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -323.946% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 26.887% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -457.718% |
| Cytokinetics, Incorporated | -496.2 Million USD | 24.075% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -994.581% |
| Nutriband Inc. | -4.87 Million USD | -7632.958% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -763.834% |
| Vor Biopharma Inc. | -126.03 Million USD | -198.918% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 108.881% |
| Evogene Ltd. | -26.39 Million USD | -1327.547% |
| ProKidney Corp. | -151.52 Million USD | -148.64% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -483.782% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4797.714% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 37.971% |
| CorMedix Inc. | -48.95 Million USD | -669.528% |
| BioLineRx Ltd. | -49.69 Million USD | -658.128% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -229.976% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -889.557% |
| Atai Life Sciences N.V. | -125.47 Million USD | -200.264% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -361.474% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -362.779% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -51.31% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1125.582% |
| MediciNova, Inc. | -9.9 Million USD | -3705.393% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -198.121% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5101.88% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1308.761% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -62.512% |
| Biomea Fusion, Inc. | -126.13 Million USD | -198.683% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -7.825% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1225.816% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -97.156% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -63.835% |
| Absci Corporation | -115.51 Million USD | -226.143% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1265.658% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -233.795% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -55.575% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1395.253% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -81.132% |
| Allakos Inc. | -196.05 Million USD | -92.161% |
| Imunon, Inc. | -21.03 Million USD | -1691.423% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -240.44% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 451.172% |
| BioAtla, Inc. | -129.68 Million USD | -190.503% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3090.836% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2277.984% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -14.953% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -802.208% |
| XOMA Corporation | -41.84 Million USD | -800.268% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -257.996% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -210.09% |
| aTyr Pharma, Inc. | -54.91 Million USD | -585.999% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -330.924% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -117.935% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -48.062% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1655.073% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4487.304% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2141.723% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4260249.677% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 211.603% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5665.882% |
| UroGen Pharma Ltd. | -65.53 Million USD | -474.866% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -321.99% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5087.159% |
| Orgenesis Inc. | -53.63 Million USD | -602.409% |
| Entera Bio Ltd. | -8.89 Million USD | -4137.364% |
| GH Research PLC | -41.22 Million USD | -813.939% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1365.474% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -353.619% |
| Xencor, Inc. | -138.63 Million USD | -171.745% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -7208.913% |
| Replimune Group, Inc. | -234.77 Million USD | -60.472% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1653.022% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2600.287% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5665.882% |
| Portage Biotech Inc. | -18.25 Million USD | -1964.011% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5101.88% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -258.937% |
| OncoCyte Corporation | -25.13 Million USD | -1398.822% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3232.585% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3188.313% |
| Purple Biotech Ltd. | 22.27 Million USD | 1791.635% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -4915.229% |
| scPharmaceuticals Inc. | -55.39 Million USD | -580.092% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1893.598% |
| HilleVax, Inc. | -133.34 Million USD | -182.533% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3026.766% |
| Tharimmune, Inc. | -9.45 Million USD | -3884.508% |
| Genprex, Inc. | -31.07 Million USD | -1112.348% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -100.189% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1100.701% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -49147.582% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -6816.644% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2391966.404% |
| Savara Inc. | -60 Million USD | -527.833% |
| Curis, Inc. | -48.33 Million USD | -679.492% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1121.613% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -7121.081% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -5077.188% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1282.547% |
| BeiGene, Ltd. | -1.2 Billion USD | 68.806% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1789.454% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 22.669% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -302.281% |
| Erasca, Inc. | -141.52 Million USD | -166.203% |
| bluebird bio, Inc. | -244.26 Million USD | -54.238% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8222.204% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 293.757% |
| DBV Technologies S.A. | -76.43 Million USD | -392.914% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8222.204% |
| Moderna, Inc. | -4.23 Billion USD | 91.112% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -784.189% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -5823.648% |
| Molecular Templates, Inc. | -10.46 Million USD | -3499.694% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -460.322% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -162.886% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -624.605% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -143.781% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -81.014% |
| MacroGenics, Inc. | -168.24 Million USD | -123.927% |
| RenovoRx, Inc. | -11.39 Million USD | -3205.932% |
| Adicet Bio, Inc. | -152.03 Million USD | -147.796% |
| Prime Medicine, Inc. | -191.29 Million USD | -96.947% |
| Aditxt, Inc. | -26.06 Million USD | -1345.545% |
| Adagene Inc. | -23.71 Million USD | -1488.306% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5053.748% |
| Quantum-Si incorporated | -111.17 Million USD | -238.887% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1090.42% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2484.374% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 408.771% |
| SciSparc Ltd. | -5.77 Million USD | -6425.966% |
| Vericel Corporation | -6.46 Million USD | -5728.342% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4252.069% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1529.545% |
| Generation Bio Co. | -138.56 Million USD | -171.894% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -353.744% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -335.744% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -56.26% |
| Invivyd, Inc. | -207.78 Million USD | -81.316% |
| Relay Therapeutics, Inc. | -373 Million USD | -1.004% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -3917.101% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1853.848% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3562.331% |
| 2seventy bio, Inc. | -216.7 Million USD | -73.853% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1841.605% |
| Clene Inc. | -40.54 Million USD | -829.314% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1464.691% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -587.539% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1308.761% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -7.623% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -925.656% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2443.373% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -263.295% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1008.005% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -121.252% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 44.945% |
| Evaxion Biotech A/S | -22.19 Million USD | -1597.274% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -357.313% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -68.85% |
| Trevena, Inc. | -35.28 Million USD | -967.626% |
| Surrozen, Inc. | -45.78 Million USD | -722.945% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -371.254% |
| Cingulate Inc. | -22.75 Million USD | -1555.349% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 5128.617% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -743.45% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4475.5% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -267.347% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -413.422% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -506.927% |
| Clearmind Medicine Inc. | -8.74 Million USD | -4209.906% |
| Kronos Bio, Inc. | -121.83 Million USD | -209.237% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -394.441% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12745.071% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -273.654% |
| Statera Biopharma, Inc. | -98.34 Million USD | -283.089% |
| ImmunityBio, Inc. | -362.25 Million USD | -4.001% |
| Korro Bio, Inc. | -84.53 Million USD | -345.672% |
| Kineta, Inc. | -15.72 Million USD | -2296.133% |
| BioVie Inc. | -32.17 Million USD | -1070.755% |
| Codexis, Inc. | -68.06 Million USD | -453.474% |
| Celularity Inc. | -192.28 Million USD | -95.928% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -69.241% |
| Celcuity Inc. | -66.23 Million USD | -468.839% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5699.208% |
| Cibus, Inc. | -318.88 Million USD | -18.145% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -776.149% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1013.178% |
| IN8bio, Inc. | -30.33 Million USD | -1141.863% |
| Kodiak Sciences Inc. | -277.32 Million USD | -35.851% |
| Annexon, Inc. | -143.72 Million USD | -162.132% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -204.339% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -482.78% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1506.995% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -6.506% |
| Eyenovia, Inc. | -25.4 Million USD | -1382.868% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1254.24% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6673.535% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -376.09% |
| Arcellx, Inc. | -89.88 Million USD | -319.163% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -729.613% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -174.581% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1111.045% |
| Moolec Science SA | -6.65 Million USD | -5562.084% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -516.219% |
| Geron Corporation | -193.94 Million USD | -94.254% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -771.024% |
| Royalty Pharma plc | 1.49 Billion USD | 125.248% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -129.495% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3938.909% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1620.712% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -120.374% |
| Humacyte, Inc. | -100.04 Million USD | -276.567% |
| Structure Therapeutics Inc. | -102.77 Million USD | -266.572% |
| 89bio, Inc. | -151.2 Million USD | -149.163% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -370.154% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2491.087% |
| Genelux Corporation | -24.16 Million USD | -1459.048% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1010.586% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -119.356% |
| Notable Labs, Ltd. | -14.65 Million USD | -2470.403% |
| Liquidia Corporation | -73.38 Million USD | -413.387% |
| Mustang Bio, Inc. | -50.72 Million USD | -642.704% |
| Immunovant, Inc. | -282.7 Million USD | -33.262% |
| Quantum-Si incorporated | -111.17 Million USD | -238.887% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -382.368% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1671.496% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -269.313% |
| Acasti Pharma Inc. | -11.31 Million USD | -3230.481% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1543.655% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2257.691% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -76.004% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -10168.1% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2271.547% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1192.122% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -810.361% |
| PepGen Inc. | -84.76 Million USD | -344.452% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1171.452% |
| United Therapeutics Corporation | 1.18 Billion USD | 131.795% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1545.386% |
| Solid Biosciences Inc. | -104.31 Million USD | -261.16% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1048.326% |
| Immuneering Corporation | -58.41 Million USD | -544.967% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7301.307% |
| Silo Pharma, Inc. | -3.85 Million USD | -9671.366% |
| Belite Bio, Inc | -31.66 Million USD | -1089.668% |
| XOMA Corporation | -41.84 Million USD | -800.268% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -457.974% |
| Bionomics Limited | -17.89 Billion USD | 97.894% |
| Apogee Therapeutics, Inc. | -93 Million USD | -305.088% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1155.897% |
| uniQure N.V. | -282.87 Million USD | -33.186% |
| Cassava Sciences, Inc. | -105.95 Million USD | -255.563% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5053.748% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -190.913% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1059.712% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4434.301% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1181.66% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6673.535% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2551.26% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4138.317% |
| Altimmune, Inc. | -95.92 Million USD | -292.732% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -412.619% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1155.897% |
| Compugen Ltd. | -12.99 Million USD | -2799.815% |
| Peak Bio, Inc. | -1356.23 USD | -27778669.088% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -659.503% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1575.162% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -55.485% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1166.537% |
| Zura Bio Limited | -62.63 Million USD | -501.462% |
| PolyPid Ltd. | -22.86 Million USD | -1547.544% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2214.721% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1166.537% |
| Instil Bio, Inc. | -159.16 Million USD | -136.694% |
| argenx SE | -425.04 Million USD | 11.365% |
| Immunome, Inc. | -109.53 Million USD | -243.964% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -648.057% |
| Verona Pharma plc | -67.83 Million USD | -455.416% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1345.679% |
| Shattuck Labs, Inc. | -91.95 Million USD | -309.696% |
| CervoMed Inc. | -7.81 Million USD | -4722.079% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -415.311% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2728.196% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -682.048% |
| Moolec Science SA | -6.65 Million USD | -5562.084% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2190.454% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -178.602% |
| AnaptysBio, Inc. | -164.41 Million USD | -129.148% |
| Design Therapeutics, Inc. | -78.19 Million USD | -381.831% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -332.835% |
| NeurAxis, Inc. | -6.66 Million USD | -5553.001% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -830.255% |
| Lumos Pharma, Inc. | -36.61 Million USD | -928.962% |
| Achilles Therapeutics plc | -75.25 Million USD | -400.623% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1345.679% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2695.355% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 7406.464% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12745.071% |
| Nutriband Inc. | -4.87 Million USD | -7632.958% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -240.083% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -579.442% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -641.097% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -469.969% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -596.087% |
| Palisade Bio, Inc. | -13.07 Million USD | -2782.51% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -729.668% |
| Beam Therapeutics Inc. | -176.48 Million USD | -113.471% |
| Neurogene Inc. | -55.58 Million USD | -577.804% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -245.149% |
| AEON Biopharma, Inc. | -48.42 Million USD | -677.931% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -289.561% |
| Sesen Bio, Inc. | -25.9 Million USD | -1354.105% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -351.034% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2893.145% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 18.199% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -420.084% |
| Athira Pharma, Inc. | -125.46 Million USD | -200.276% |
| Vaccinex, Inc. | -22.88 Million USD | -1546.249% |
| HCW Biologics Inc. | -25.71 Million USD | -1364.952% |
| XOMA Corporation | -41.84 Million USD | -800.268% |
| Nektar Therapeutics | -137.42 Million USD | -174.145% |
| Arvinas, Inc. | -401.5 Million USD | 6.166% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4260249.677% |
| Merus N.V. | -156.54 Million USD | -140.659% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -275.763% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -988.226% |
| Rezolute, Inc. | -70.42 Million USD | -434.973% |
| Clene Inc. | -40.54 Million USD | -829.314% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2200.239% |
| BeyondSpring Inc. | -23.11 Million USD | -1529.939% |
| Synlogic, Inc. | -55.16 Million USD | -582.99% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2001.311% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3380.636% |
| Peak Bio, Inc. | -1356.23 USD | -27778669.088% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -830.163% |
| Krystal Biotech, Inc. | -109.72 Million USD | -243.347% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -190.832% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -9.834% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -7838.216% |
| MannKind Corporation | 8.67 Million USD | 4441.369% |
| Ikena Oncology, Inc. | -75.41 Million USD | -399.548% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3805.297% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -460.381% |
| Gossamer Bio, Inc. | -183.75 Million USD | -105.021% |
| CohBar, Inc. | -12.38 Million USD | -2941.128% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -642.733% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1265.658% |
| Legend Biotech Corporation | -439.48 Million USD | 14.276% |
| Mural Oncology plc | -194.63 Million USD | -93.561% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -461.107% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2233.464% |
| Disc Medicine, Inc. | -91.12 Million USD | -313.436% |
| Champions Oncology, Inc. | -7.35 Million USD | -5021.588% |
| REGENXBIO Inc. | -268.12 Million USD | -40.509% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3414.997% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -575.701% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -866.986% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -229.446% |
| Vaxart, Inc. | -83.34 Million USD | -352.019% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4321.874% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -780.365% |
| Cellectis S.A. | -106.62 Million USD | -253.332% |
| Longeveron Inc. | -21.02 Million USD | -1691.545% |
| Repare Therapeutics Inc. | -116.22 Million USD | -224.153% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -40.668% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -398.042% |
| Revolution Medicines, Inc. | -487.18 Million USD | 22.669% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5563.62% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -757.132% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -405.086% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -441.027% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3321.524% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 108.746% |
| Denali Therapeutics Inc. | -196.69 Million USD | -91.533% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4252.069% |
| Veru Inc. | -93.78 Million USD | -301.722% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1514.917% |
| Cingulate Inc. | -22.75 Million USD | -1555.349% |
| Passage Bio, Inc. | -108.38 Million USD | -247.585% |
| Context Therapeutics Inc. | -25.07 Million USD | -1402.611% |
| Exicure, Inc. | -14.99 Million USD | -2412.297% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -82.829% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -827.987% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3777.189% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -104.356% |
| Nuvalent, Inc. | -149.49 Million USD | -152.016% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4485.208% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -324.591% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1713.536% |
| OmniAb, Inc. | -69.41 Million USD | -442.71% |
| Anew Medical, Inc. | -1.3 Million USD | -28861.594% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2849.996% |
| Lipocine Inc. | -17.93 Million USD | -2001.081% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -449.887% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -394.726% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -889.47% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -853.131% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1583.095% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 35.027% |
| Ocugen, Inc. | -65.53 Million USD | -474.91% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -301.364% |
| Q32 Bio Inc. | -92.1 Million USD | -309.051% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1657.283% |
| Alumis Inc. Common Stock | -158.17 Million USD | -138.183% |
| Equillium, Inc. | -14.52 Million USD | -2494.298% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -503.698% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4666.891% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1897.041% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -702.42% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -247.338% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3047.398% |
| Dominari Holdings Inc. | -21.79 Million USD | -1628.501% |
| Edesa Biotech, Inc. | -9.22 Million USD | -3984.939% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1377.312% |
| Bio-Techne Corporation | 206.68 Million USD | 282.278% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 3.766% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 296.19% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -184.814% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -881.334% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -149.333% |
| Nkarta, Inc. | -131.65 Million USD | -186.171% |
| BioCardia, Inc. | -11.64 Million USD | -3135.52% |
| Iterum Therapeutics plc | -47.46 Million USD | -693.68% |